The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Reeth Mark D since year 2005.
The trader's CIK number is 1399353.
At the time of this reporting, Reeth Mark D is the Gen Counsel&VP Corp of Salix Pharmaceuticals Ltd .
(stock ticker symbol SLXP).
See this page for all insider trading activities at Salix Pharmaceuticals Ltd .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2012-05-01||SLXP||Salix Pharmaceuticals Ltd||Sale||1,000||48.91||48,910|
|2011-07-05||SLXP||Salix Pharmaceuticals Ltd||Sale||7,357||40.32||296,671|
|2011-05-16||SLXP||Salix Pharmaceuticals Ltd||Sale||3,377||39.84||134,536|
|2010-06-14||SLXP||Salix Pharmaceuticals Ltd||Sale||4,278||36.24||155,030|
|2010-05-17||SLXP||Salix Pharmaceuticals Ltd||Sale||3,377||37.38||126,225|
|2009-11-23||SLXP||Salix Pharmaceuticals Ltd||Sale||3,377||23.64||79,849|
|2008-05-01||SLXP||Salix Pharmaceuticals Ltd||Sale||1,622||7.16||11,616|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Reeth Mark D (Gen Counsel&VP Corp of Salix Pharmaceuticals Ltd at the time of this reporting) see the Securities and Exchange Commission (SEC) website.